The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications.
- DOI
- 10.1016/j.neubiorev.2023.105149
- Published
- 2023 Jun
- Container
- Neuroscience and biobehavioral reviews
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.neubiorev.2023.105149,
title = {The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications.},
author = {Cortese S and McGinn K and Højlund M and Apter A and Arango C and Baeza I and Banaschewski T and Buitelaar J and Castro-Fornieles J and Coghill D and Cohen D and Grünblatt E and Hoekstra PJ and James A and Jeppesen P and Nagy P and Pagsberg AK and Parellada M and Persico AM and Purper-Ouakil D and Roessner V and Santosh P and Simonoff E and Stevanovic D and Stringaris A and Vitiello B and Walitza S and Weizman A and Wohlfarth T and Wong ICK and Zalsman G and Zuddas A and Moreno C and Solmi M and Correll CU},
year = {2023},
journal = {Neuroscience and biobehavioral reviews},
doi = {10.1016/j.neubiorev.2023.105149},
url = {https://doi.org/10.1016/j.neubiorev.2023.105149}
}RIS
TY - JOUR TI - The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications. AU - Cortese S AU - McGinn K AU - Højlund M AU - Apter A AU - Arango C AU - Baeza I AU - Banaschewski T AU - Buitelaar J AU - Castro-Fornieles J AU - Coghill D AU - Cohen D AU - Grünblatt E AU - Hoekstra PJ AU - James A AU - Jeppesen P AU - Nagy P AU - Pagsberg AK AU - Parellada M AU - Persico AM AU - Purper-Ouakil D AU - Roessner V AU - Santosh P AU - Simonoff E AU - Stevanovic D AU - Stringaris A AU - Vitiello B AU - Walitza S AU - Weizman A AU - Wohlfarth T AU - Wong ICK AU - Zalsman G AU - Zuddas A AU - Moreno C AU - Solmi M AU - Correll CU PY - 2023 JO - Neuroscience and biobehavioral reviews DO - 10.1016/j.neubiorev.2023.105149 UR - https://doi.org/10.1016/j.neubiorev.2023.105149 ER -
APA
S, C., K, M., M, H., A, A., C, A., I, B., T, B., J, B., J, C., D, C., D, C., E, G., PJ, H., A, J., P, J., P, N., AK, P., M, P., AM, P., D, P., V, R., P, S., E, S., D, S., A, S., B, V., S, W., A, W., T, W., ICK, W., G, Z., A, Z., C, M., M, S., & CU, C. (2023). The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications.. Neuroscience and biobehavioral reviews. https://doi.org/10.1016/j.neubiorev.2023.105149
Source records
- pubmed · retrieved 2026-09-26T15:42:54.096Z